Effective Management Drove CNO Financials' (CNO) Terrific Performance
In its first-quarter 2025 investor letter, FPA Queens Road Small Cap Value Fund highlighted stocks such as CNO Financial Group, Inc. (NYSE:CNO). CNO Financial Group, Inc. (NYSE:CNO) is an insurance holding company that develops and markets health insurance, annuity, individual life insurance, and other insurance products. The one-month return of CNO Financial Group, Inc. (NYSE:CNO) was -4.98%, and its shares gained 34.54% of their value over the last 52 weeks. On May 21, 2025, CNO Financial Group, Inc. (NYSE:CNO) stock closed at $37.78 per share with a market capitalization of $3.746 billion.
FPA Queens Road Small Cap Value Fund stated the following regarding CNO Financial Group, Inc. (NYSE:CNO) in its Q1 2025 investor letter:
"CNO Financial Group, Inc. (NYSE:CNO) is a life insurer that also sells supplemental medical and group insurance. Under CEO Gary Bhojwani, the company has done a terrific job growing its agent force, growing its direct-to consumer ('D2C') channel, adding a suite of third-party products, bolting on a worksite channel (Optavise), and incrementally optimizing its balance sheet. The company generates a lot of cash and has reduced shares outstanding by nearly a third since 2019.12 CNO had an exceptional 2024 with strong earnings growth and achieved a nearly 12% return on equity. Shares performed well but continue to trade at the reasonable price of 10x EPS."
A financial analyst pouring over graphs and charts related to annuities and fixed index annuities.
CNO Financial Group, Inc. (NYSE:CNO) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 29 hedge fund portfolios held CNO Financial Group, Inc. (NYSE:CNO) at the end of the fourth quarter, compared to 22 in the third quarter. While we acknowledge the potential of CNO Financial Group, Inc. (NYSE:CNO) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the undervalued AI stock set for massive gains.
In another article, we covered CNO Financial Group, Inc. (NYSE:CNO) and shared Hotchkis & Wiley Mid-Cap Value Fund's views on the company in the previous quarter. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors.
READ NEXT: Michael Burry Is Selling These Stocks and A New Dawn Is Coming to US Stocks.
Disclosure: None. This article is originally published at Insider Monkey.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Clearwater Analytics Gains As Investors Eye Growth Beyond Acquisition Jitters
Clearwater Analytics Holdings (NYSE:CWAN) shares climbed Tuesday as investors looked past recent acquisition concerns, betting on sustained double-digit growth and fresh product rollouts to drive long-term momentum. Goldman Sachs analyst Gabriela Borges upgraded Clearwater Analytics Holdings (NYSE:CWAN) rating to Buy from Neutral with a price forecast of $27 on Monday. Borges said the stock's 30% drop over the past six months, compared with a 9% Nasdaq gain, reflects investor concerns over the quality of acquired assets and Clearwater's ability to integrate multiple acquisitions argued those risks are now priced in and sees a clear catalyst path, including the September 3 Analyst Day. Borges expects Clearwater's core business to sustain 20%-plus annual growth over the next three to five years, driven by its automation platform, strong network effects, and cross-sell opportunities. She said Clearwater's net revenue retention (NRR) is already improving, with potential upside from cross-sell as the company releases about five new products annually, targeting growth in alternative investments through partnerships with Blackstone (NYSE:BX) and PIMCO. She added that macro tailwinds could further boost results. Goldman projects three consecutive 25-basis-point rate cuts starting in September, which would lift fixed-income asset prices, about 80% of Clearwater's client AUM, and support revenue through its AUM-linked pricing model. Increased capital market activity and IPO volume could also add one to two percentage points of growth in the corporate segment, which accounts for about 16% of revenue. Borges acknowledged investor concerns about acquisition execution, citing mixed results with past deals and the challenge of integrating Enfusion, representing about 13% of run-rate sales. Still, she forecasts Enfusion's growth improving from 13% to 15% by 2027, short of management's 20% target, but believes Clearwater can still achieve total business growth of 19%. She noted Enfusion's recent momentum, including a record-high bookings quarter and 49 new client wins in the second quarter. Longer term, Borges is constructive on Clearwater's plan to build an end-to-end platform with a single security master and data plane for institutional investors, capable of providing a complete, real-time portfolio view across public and private markets. She believes the market underestimates the combined platform's ability to reach a Rule of 40 profile, even before the vision is fully realized. Price Action: CWAN shares traded higher by 3.55% to $19.11 at last check Tuesday. Photo via Shutterstock Latest Ratings for CWAN Date Firm Action From To Mar 2022 Morgan Stanley Maintains Equal-Weight Mar 2022 Credit Suisse Maintains Outperform Mar 2022 RBC Capital Maintains Outperform View More Analyst Ratings for CWAN View the Latest Analyst Ratings UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? This article Clearwater Analytics Gains As Investors Eye Growth Beyond Acquisition Jitters originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.
Yahoo
19 minutes ago
- Yahoo
If You'd Invested $1,000 in Block (XYZ) 5 Years Ago, Here's How Much You'd Have Today
Key Points Spoiler alert: It wouldn't be more. Block has diversified over the years, but not in a particularly disciplined or clever way. 10 stocks we like better than Block › In its relatively brief life as a publicly traded company, Block (NYSE: XYZ) has gone through several transformations. It's been a near pure-play transaction processor, then a burgeoning financial services company, then a major institutional investor in cryptocurrency. Through these changes, the once-impressive growth rates of its core businesses cooled off in the early part of this decade. Since then, the stock has been something of a laggard. Blocked A $1,000 outlay on Block half a decade ago would have withered to $524 as I write this, which, as far as financial sector stocks go, is underwhelming. Every one of the so-called "big four" U.S. banks has done far better, as has the benchmark S&P 500 index. One major problem is that the great motors of Block's growth in the early years slowed notably as they matured. At one point, the company's foundational point-of-sale terminals seemed like they were mushrooming into every corner coffee shop and bistro. Since then, though, the company hasn't managed to poach many larger businesses as clients. It did plunge enthusiastically into Bitcoin, and today the cryptocurrency is a cornerstone of its business. This hasn't really moved the needle on overall fundamentals, however. In spite of its popularity, widespread adoption of the crypto is years away at best. Meanwhile it remains a clunky asset to buy, let alone use to pay for most goods. New map wanted? I think that after contracting crypto fever, Block essentially lost its way. It became something of a Bitcoin hound like many investors (and not a few companies), to the detriment of the parts of its business that were working, even if not growing hotly. These days, I think that Block is an investment only for Bitcoin fans. While that's certainly not a bad stance to take given the cryptocurrency's impressive rise -- hopefully it won't be crashing anytime soon! -- I think there are better ways to profit from the digital coin and better fintech stocks to own. Should you buy stock in Block right now? Before you buy stock in Block, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Block wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 11, 2025 Eric Volkman has positions in Bitcoin. The Motley Fool has positions in and recommends Bitcoin and Block. The Motley Fool has a disclosure policy. If You'd Invested $1,000 in Block (XYZ) 5 Years Ago, Here's How Much You'd Have Today was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
21 minutes ago
- Business Wire
Hyperscience Recognized on the 2025 Inc. 5000 List of Fastest-Growing Private Companies in America
NEW YORK--(BUSINESS WIRE)-- Hyperscience, a market leader in hyperautomation and a provider of enterprise AI infrastructure software, today announced its inclusion on the prestigious 2025 Inc. 5000 list of America's fastest-growing private companies. The company's proven success in delivering operational efficiencies across numerous verticals has earned it a spot on the list for the first time. This placement comes on the heels of a breakout year marked by the release of the company's Optical Reasoning and Cognition Agent (ORCA), its next-generation Vision-Language Model (VLM), and rapid adoption of its platform across government agencies, global enterprises, and regulated industries. 'Being recognized on the Inc. 5000 list for the first time reflects the years of hard work and commitment of our teams, and is a testament to our achievements in leading the charge for intelligent automation,' said Andrew Joiner, CEO of Hyperscience. 'At Hyperscience, we're not just building AI, we're reshaping how the world works with information. This placement reinforces our mission to deliver AI that understands, empowers, and accelerates outcomes for organizations everywhere.' Hyperscience transforms organizations everywhere with a turnkey AI platform that accelerates the processing of documents and forms that flow through an enterprise's back office. Designed with a 'human-in-the-loop' approach, this platform leverages the strengths of both humans and machines. Hyperscience comprehensively manages data from input to extraction, orchestrating end-to-end processes. With industry-leading accuracy (99.5 percent) and automation (98 percent), Hyperscience automates tedious tasks, enabling workforces to spend their time on higher-level projects. The Inc. 5000 list, compiled annually by Inc. magazine, ranks the 5000 fastest-growing private companies in the United States based on revenue growth over the past three years. Making the Inc. 5000 is a significant achievement that places Hyperscience among the most dynamic and successful businesses in the country. For the full list, company profiles, and a searchable database by industry and location, visit: About Hyperscience Hyperscience is a market leader in hyperautomation and a provider of enterprise AI infrastructure software. The Hyperscience Hypercell platform unlocks the value of an organization's back office data through the automation of end-to-end processes, and transforms complex documents into LLM and RAG-ready data to power new enterprise GenAI experiences. This enables organizations to transform manual, siloed processes into a strategic advantage, resulting in a faster path to decisions, actions, and revenue; positive and engaging customer, public, and patient experiences; and dramatic increases in productivity. Leading organizations across the globe rely on Hyperscience to drive their hyperautomation initiatives, including American Express, Charles Schwab, HM Revenue and Customs, Mars, Stryker, The United States Social Security Administration, and The United States Department of Veterans Affairs. The company is funded by top tier investors including Bessemer Venture Partners, Battery, FirstMark, Stripes, and Tiger Global.
